天美传媒

Abstract

Respiratory pharmacology is a crucial field that explores the mechanisms and therapeutic applications of drugs used to treat respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary hypertension, and cystic fibrosis. This article provides an overview of the pathophysiology of common respiratory disorders and the pharmacological agents used in their treatment, including bronchodilators, anti-inflammatory agents, mucolytics, pulmonary vasodilators, antibiotics, and antivirals. Recent advancements, such as biologics and personalized medicine, have significantly improved treatment outcomes, particularly for severe and refractory cases. However, challenges remain, including drug resistance and the complexity of overlapping pathologies. The future of respiratory pharmacology lies in developing more targeted therapies with fewer side effects, driven by advances in molecular research, personalized medicine, and artificial intelligence. This article underscores the importance of respiratory pharmacology in improving patient outcomes and highlights the need for ongoing research and innovation in this dynamic field.